- Home
- IPST vs PPBT Comparison
IPST vs PPBT Comparison
Compare IPST & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPST | PPBT |
|---|---|---|
| Founded | 2011 | 2010 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 2.4M |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IPST | PPBT |
|---|---|---|
| Price | $2.69 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 256.5K | 21.6K |
| Earning Date | 11-17-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,402,488.00 | N/A |
| Revenue This Year | $66.82 | N/A |
| Revenue Next Year | $60.33 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.41 | N/A |
| 52 Week Low | $0.26 | $0.41 |
| 52 Week High | $308.00 | $5.18 |
Technical Indicators
Market Signals| Indicator | IPST | PPBT |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 27.31 |
| Support Level | $2.51 | $0.56 |
| Resistance Level | $2.80 | $1.60 |
| Average True Range (ATR) | 0.23 | 0.10 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 40.18 | 0.00 |
Price Performance
Historical ComparisonAbout IPST Heritage Distilling Holding Company Inc.
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.